Cancer
Therapeutics Market Outlook Key Findings, Growth by Region, Key Players
Profiles and Future Prospects (2021-2031)

The cancer therapeutics market size is expected to reach
US$ 5,31,538.02 million by 2031 from US$ 2,30,423.56 million in 2024. The
market is estimated to record a CAGR of 12.8% from 2025 to 2031.

Executive Summary and Global Market Analysis

The global cancer therapeutics market is experiencing
considerable expansion, driven by the escalating burden of breast and lung
cancer and substantial investments in oncology research and development. Cancer
therapeutics encompasses a wide range of treatments aimed at managing or curing
cancer. Key treatment metrics often used are chemotherapy, radiation therapy,
immunotherapy, targeted therapy, hormone therapy, surgical interventions, and
stem cell therapy. All these strategies strive to eliminate or control
cancerous cells, alleviate patient symptoms, and enhance overall patient
survival. Depending on the cancer type, stage, and the patient's general
health, a combination of these treatments is often employed to maximize
effectiveness.

Cancer Therapeutics Market
Segmentation Analysis

The derivation of the cancer therapeutics market analysis
relies on key segments: therapy type, indication, and distribution channel.

By therapy type, the market is segmented into chemotherapy,
targeted therapy, radiation therapy, hormone therapy, and other therapy types.
Chemotherapy was the dominant segment in 2024.

In terms of indications, the market is segmented across
blood cancer, lung cancer, breast cancer, colorectal cancer, prostate cancer,
stomach cancer, cervical cancer, liver and intrahepatic bile duct cancer,
thyroid cancer, and other indications. Lung cancer held the largest share of
the market in 2024.

By distribution channel, the market is categorized into
hospital pharmacies, retail pharmacies, and online stores. Hospital pharmacies
maintained the largest share of the market in 2024.

Download our Sample PDF
Report

@ https://www.businessmarketinsights.com/sample/BMIRE00031299

Cancer Therapeutics Market Drivers and Opportunities

As per the World Health Organization's media center,
approximately 1 in every 6 deaths globally is caused by various types of
cancer. In 2022, there were an estimated 20 million new cancer cases and 9.7
million deaths associated with the disease; this burden is projected to
increase by roughly 77% by 2050, further straining health systems and
communities. The American Cancer Society reports that 5–10% of all cancers are
due to inherited genes. Numerous genes linked to cancer predisposition have
been identified. For example, mutations in inherited cancer predisposition
genes like BRCA1 and BRCA2 significantly increase the risk of developing
breast, ovarian, and prostate cancers. Breast cancer is widely considered the
most prevalent cancer among women, with its incidence continuously rising
worldwide due to factors such as environmental impact, genetic susceptibility,
hormone imbalances, and lifestyle changes. Furthermore, breast cancer is among
the most prevalent cancers in the U.S.

About Us:

Business Market Insights is a market research platform that
provides subscription service for industry and company reports. Our research
team has extensive professional expertise in domains such as Electronics &
Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy
& Power; Healthcare; Manufacturing & Construction; Food &
Beverages; Chemicals & Materials; and Technology, Media, &
Telecommunications